Sanders blasts high cancer drug prices after RVMD approval
Sen. Bernie Sanders said the cost of new cancer drugs is driving financial ruin for patients, citing a 42% life-savings depletion figure without naming the source. The post followed Revolution Medicines' late-August FDA approval and reported pricing for its new pancreatic cancer therapy.